TREA

97371562 - CTX112

Follow

Information

  • Trademark
  • 97371562
  • Serial Number
    97371562
  • Filing Date
    April 20, 2022
    2 years ago
  • Transaction Date
    April 03, 2024
    a month ago
  • Status Date
    March 20, 2024
    2 months ago
  • Published for Opposition Date
    April 23, 2024
    27 days ago
  • Location Date
    March 20, 2024
    2 months ago
  • Status Code
    681
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    SINGH, DEEP K
  • Attorney Docket Number
    33324/60052
    Attorney Name
    Tiffany D. Gehrke
    Law Office Assigned Location Code
    M40
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
CTX112
Case File Statements
  • GS0051: Cells for medical or clinical use in the field of CAR T cell therapy for the treatment of cancer and autoimmune diseases; pharmaceutical and biopharmaceutical agents for the treatment of cancer in the field of CAR T cell therapy; gene therapy products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of cancer in the field of CAR T cell therapy
  • GS0421: Gene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders in the field of CAR T cell therapy for the treatment of cancer and autoimmune diseases; gene editing, namely, pharmaceutical research and development in the field of CAR T cell therapy for the treatment of cancer and autoimmune diseases
Case File Event Statements
  • 4/3/2024 - a month ago
    22 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 3/15/2024 - 2 months ago
    21 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 2/16/2024 - 3 months ago
    20 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 2/16/2024 - 3 months ago
    19 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 2/16/2024 - 3 months ago
    18 - TEAS REQUEST FOR RECONSIDERATION RECEIVED Type: ERFR
  • 12/18/2023 - 5 months ago
    17 - APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Type: XELG
  • 12/18/2023 - 5 months ago
    16 - APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Type: XELR
  • 10/2/2023 - 7 months ago
    15 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN
  • 10/2/2023 - 7 months ago
    14 - FINAL REFUSAL E-MAILED Type: GNFR
  • 10/2/2023 - 7 months ago
    13 - FINAL REFUSAL WRITTEN Type: CNFR
  • 8/11/2023 - 9 months ago
    12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 8/10/2023 - 9 months ago
    11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 8/10/2023 - 9 months ago
    10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 7/3/2023 - 10 months ago
    9 - ASSIGNED TO EXAMINER Type: DOCK
  • 5/11/2023 - a year ago
    8 - APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Type: XELG
  • 5/11/2023 - a year ago
    7 - APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Type: XELR
  • 2/14/2023 - a year ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 2/14/2023 - a year ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 2/14/2023 - a year ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 2/7/2023 - a year ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 4/26/2022 - 2 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 4/23/2022 - 2 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP